BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 3421574)

  • 21. Imaging of adrenal masses.
    Korobkin M; Francis IR
    Urol Clin North Am; 1997 Aug; 24(3):603-22. PubMed ID: 9275981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited significance of asymmetric adrenal visualization on dexamethasone-suppression scintigraphy.
    Gross MD; Shapiro B; Freitas JE
    J Nucl Med; 1985 Jan; 26(1):43-8. PubMed ID: 2981301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidentally discovered adrenal masses: a functional and morphological study.
    Corsello SM; Della Casa S; Bollanti L; Rufini V; Rota CA; Danza F; Colasanti S; Vellante C; Troncone L; Barbarino A
    Exp Clin Endocrinol; 1993; 101(3):131-7. PubMed ID: 8223980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging.
    Burt M; Heelan RT; Coit D; McCormack PM; Bains MS; Martini N; Rusch V; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1994 Feb; 107(2):584-8; discussion 588-9. PubMed ID: 8302078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses.
    Dwamena BA; Kloos RT; Fendrick AM; Gross MD; Francis IR; Korobkin MT; Shapiro B
    J Nucl Med; 1998 Apr; 39(4):707-12. PubMed ID: 9544685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report: failure of adrenal scintigraphy to exhibit 131I cholesterol uptake in a CT-demonstrated, surgically proven aldosteronoma.
    Salam Z; Lubbos H; Martinez C; Mozley PD; Miller JL; Rose LI
    Am J Med Sci; 1996 Sep; 312(3):130-2. PubMed ID: 8783680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adrenal imaging.
    Korobkin M; Francis IR
    Semin Ultrasound CT MR; 1995 Aug; 16(4):317-30. PubMed ID: 7576778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship of I-131 6 beta-iodomethyl-19-norcholesterol (NP-59) adrenal cortical uptake to indices of androgen secretion in women with hyperandrogenism.
    Gross MD; Shapiro B; Freitas JE; Ayers J; Swanson DP; Woodbury MC; Schteingart DE; Beierwaltes WH
    Clin Nucl Med; 1984 May; 9(5):264-70. PubMed ID: 6235079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidentally discovered adrenal masses in the Department of Internal Medicine, Endocrinology and Hemostatic Disorders, Medical University of Gdansk].
    Babińska A; Sworczak K; Siekierska-Hellmann M; Lewczuk A; Błaut K; Obołoiczyk L; Wiśniewski P; Zielonko J; Kaska L; Lachiński A
    Wiad Lek; 2006; 59(11-12):744-50. PubMed ID: 17427485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role of adrenal gland x-ray computed tomography and scintigraphy using radiolabelled norcholesterol in the etiological diagnosis of primary hyperaldosteronism].
    Abram M; Peltier P; Murat A; Chupin M; Dupas B; Gaillard F; Chatal JF; Charbonnel B
    Rev Med Interne; 1993; 14(7):691-7. PubMed ID: 8191071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imaging of adrenal masses.
    Lockhart ME; Smith JK; Kenney PJ
    Eur J Radiol; 2002 Feb; 41(2):95-112. PubMed ID: 11809539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Incidental discovery of adrenal neoplasms: our experience].
    Bellantone R; Ferrante A; Raffaelli M; Boscherini M; Rubino F; Crucitti F
    Ann Ital Chir; 1995; 66(4):439-48. PubMed ID: 8686994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nuclear medicine methods for the diagnosis of adrenal tumors].
    Gregianin M; Bui F; Varotto L; Zucchetta P; Macri C
    Minerva Endocrinol; 1995 Mar; 20(1):27-38. PubMed ID: 7651280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accumulation of iodine-131-iodocholesterol in renal cell carcinoma adrenal metastases.
    Tsukamoto E; Itoh K; Kanegae K; Kobayashi S; Koyanagi T; Tamaki N
    J Nucl Med; 1998 Apr; 39(4):656-8. PubMed ID: 9544676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal imaging with 131I-19-iodocholesterol in the diagnostic evaluation of patients with aldosteronism.
    Seabold JE; Cohen EL; Beierwaltes WH; Hinerman DL; Nishiyama RH; Bookstein JJ; Ice RD; Balachandran S
    J Clin Endocrinol Metab; 1976 Jan; 42(1):41-51. PubMed ID: 1249193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adrenal incidentaloma: proposal for a correct treatment].
    Favia G; Lumachi F; Gregianin M; Polistina F; Borsato S; D'Amico DF
    Ann Ital Chir; 1997; 68(4):517-22. PubMed ID: 9494183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of 18F-FDG PET-CT and 131I-norcholesterol scintigraphy in the characterization of high-risk adrenal masses.
    Riaz S; Syed R; Aziz TA; Alnaim A; Chung TT; Wan S; Kurzawinski TR; Bomanji J
    Nucl Med Commun; 2020 Mar; 41(3):189-195. PubMed ID: 31895761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 131I-6beta-iodomethyl-19-norcholesterol SPECT/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results.
    Yen RF; Wu VC; Liu KL; Cheng MF; Wu YW; Chueh SC; Lin WC; Wu KD; Tzen KY; Lu CC;
    J Nucl Med; 2009 Oct; 50(10):1631-7. PubMed ID: 19759122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional imaging of adrenal cortex.
    Prado-Wohlwend S;
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):393-404. PubMed ID: 33222841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.